Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LABORATORY CORPORATION OF AMERICA HOLDINGS

NPI: 1063556017 · MC KEES ROCKS, PA 15136 · Clinical Medical Laboratory · NPI assigned 02/16/2007

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more

$175K
Total Medicaid Paid
6,326
Total Claims
5,493
Beneficiaries
17
Codes Billed
2018-01
First Month
2024-08
Last Month

Provider Details

Authorized OfficialWILLIAMS, KIMBERLY (VP)
NPI Enumeration Date02/16/2007

Related Entities

Other providers sharing the same authorized official: WILLIAMS, KIMBERLY

ProviderCityStateTotal Paid
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $1.44B
LABORATORY CORPORATION OF AMERICA HOLDINGS RARITAN NJ $717.47M
LABORATORY CORPORATION OF AMERICA HOLDINGS DUBLIN OH $617.02M
LABORATORY CORPORATION OF AMERICA HOLDINGS BIRMINGHAM AL $289.12M
LABORATORY CORPORATION OF AMERICA PHOENIX AZ $265.90M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $264.26M
LABORATORY CORPORATION OF AMERICA HOLDINGS CHARLESTON WV $220.04M
LABORATORY CORPORATION OF AMERICA SEATTLE WA $186.69M
LABORATORY CORPORATION OF AMERICA TAMPA FL $171.13M
LABORATORY CORPORATION OF AMERICA SAN DIEGO CA $147.14M
LABORATORY CORPORATION OF AMERICA HOUSTON TX $103.81M
LABORATORY CORPORATION OF AMERICA ENGLEWOOD CO $77.80M
LABORATORY CORPORATION OF AMERICA DALLAS TX $77.42M
LABORATORY CORPORATION OF AMERICA BURLINGTON NC $59.75M
MEDTOX LABORATORIES, INC SAINT PAUL MN $47.72M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $15.65M
LABORATORY CORPORATION OF AMERICA SAN ANTONIO TX $11.67M
TRI-CITIES LABORATORY, LLC KENNEWICK WA $8.69M
LABORATORY CORPORATION OF AMERICA HOLDINGS MONROE LA $3.39M
LABORATORY CORPORATION OF AMERICA ITASCA IL $3.37M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 661 $2K
2019 922 $119.00
2020 326 $3K
2021 1,838 $71K
2022 2,013 $99K
2023 486 $507.72
2024 80 $32.43

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,101 1,996 $128K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 53 53 $42K
87070 500 438 $2K
86769 12 12 $840.08
80053 Comprehensive metabolic panel 1,179 907 $678.32
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,216 935 $595.81
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 507 507 $548.51
87081 25 25 $74.24
36415 Collection of venous blood by venipuncture 352 270 $67.50
80061 Lipid panel 37 37 $35.84
83036 Hemoglobin; glycosylated (A1C) 48 48 $31.47
87086 Culture, bacterial; quantitative colony count, urine 24 24 $15.57
85610 19 14 $6.86
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 38 38 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 61 58 $0.00
80197 25 13 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 129 118 $0.00